SCHEMBL19061885

SCHEMBL19061885

Cc1cccc(CSC2=NCN(Cc3cccnc3)CN2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.52
▸ KMT2A Q03164 4/20 0.52
▸ THRB P10828 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ PKM P14618 1/20 0.46
▸ TRPV6 Q9H1D0 1/20 0.44
▸ KDM4E B2RXH2 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ LMNA P02545 2/20 0.43
▸ HTT P42858 2/20 0.43
▸ CHRNB2 P17787 1/20 0.41
▸ CHRNA4 P43681 1/20 0.41
▸ GRIN1 Q05586 2/20 0.41
▸ GRIN2B Q13224 2/20 0.41
▸ PTGER2 P43116 1/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ CYP2C19 P33261 2/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ PSMD14 O00487 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19061883 0.89 MEN1 (0.48) MEN1KMT2ATHRBHSD17B10PKM
SCHEMBL19061459 0.87 RAB9A (0.46) MEN1KMT2AHSD17B10PKMKDM4E
SCHEMBL19061887 0.87 L3MBTL1 (0.51) MEN1KMT2AHSD17B10PKMLMNA
SCHEMBL19019917 0.87 TDP1 (0.46) MEN1KMT2AHSD17B10PKMTRPV6
SCHEMBL19019864 0.86 GFER (0.53) MEN1KMT2AHSD17B10PKMTRPV6
SCHEMBL19019922 0.86 MAPK1 (0.50) MEN1KMT2AHSD17B10PKMTRPV6
SCHEMBL19062032 0.84 MAPT (0.46) MEN1KMT2AHSD17B10PKMALDH1A1
SCHEMBL19061464 0.84 GSK3A (0.41) MEN1KMT2AHSD17B10PKMALDH1A1
SCHEMBL19061599 0.84 KDM4E (0.53) HSD17B10PKMKDM4EALDH1A1GRIN1
SCHEMBL19061952 0.84 CYP1A2 (0.51) MEN1KMT2AHSD17B10PKMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3184514-A1 AUTOPHAGY INHIBITORS Deutsches Krebsforschungszentrum (DE) 2017-06-28 — — EP disclosed
Send feedback